標(biāo)題: Titlebook: GI Surgery Annual; Volume 25 T.K. Chattopadhyay (Editor-in-Chief),Peush Sahni,S Book 2019 Indian Association of Surgical Gastroenterology 2 [打印本頁(yè)] 作者: Herbaceous 時(shí)間: 2025-3-21 18:46
書(shū)目名稱(chēng)GI Surgery Annual影響因子(影響力)
書(shū)目名稱(chēng)GI Surgery Annual影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)GI Surgery Annual網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)GI Surgery Annual網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)GI Surgery Annual被引頻次
書(shū)目名稱(chēng)GI Surgery Annual被引頻次學(xué)科排名
書(shū)目名稱(chēng)GI Surgery Annual年度引用
書(shū)目名稱(chēng)GI Surgery Annual年度引用學(xué)科排名
書(shū)目名稱(chēng)GI Surgery Annual讀者反饋
書(shū)目名稱(chēng)GI Surgery Annual讀者反饋學(xué)科排名
作者: 代替 時(shí)間: 2025-3-22 00:08
Bridging Therapy for HCC,chapter we will discuss available evidence on the efficacy of bridging therapy for HCC. We will also discuss the current role of downstaging in the management of HCC. Towards the end we would like to highlight the role of bridging therapy in Indian scenario and also touch upon guidelines from Asian 作者: 心胸狹窄 時(shí)間: 2025-3-22 02:37
Biologics and Inflammatory Bowel Disease,become an important part of the therapeutics of inflammatory bowel disease. The various biologics available, indications and efficacy of biologics in the management of inflammatory bowel diseases, the risks involved in their usage, and practical aspects in various clinical settings are discussed in the current review.作者: gastritis 時(shí)間: 2025-3-22 07:27
Tumor Markers in GI and HPB Cancers,noembryonic proteins, and oncoproteins) or carbohydrates. They may be elevated when there is no cancer (false positive) or may be normal or low when there is a cancer (false negative). They are usually measured in blood, urine, and other body fluids or identified in tumor tissue.作者: 無(wú)能的人 時(shí)間: 2025-3-22 12:10
Adjuncts to Liver Resection,liver resection in 1888. The initial approaches focussed on directly splitting the parenchyma by mechanical means (finger ‘fracture’ or ‘Kelly-clysis’) with bleeding controlled by sutures as it arose. Pringle, in 1908, reported temporary occlusion of vascular inflow at the porta as a means of reducing blood loss while transecting the liver.作者: Tincture 時(shí)間: 2025-3-22 16:16 作者: Tincture 時(shí)間: 2025-3-22 19:55 作者: 無(wú)動(dòng)于衷 時(shí)間: 2025-3-22 22:29
2367-3435 As in the previous volumes, the chapter on advances in GI surgery reviews the?important new developments in the field...The GI Surgery Annual 25th Volume provides up-to-date information on current hot topics..978-981-13-3227-2Series ISSN 2367-3435 Series E-ISSN 2367-3443 作者: 統(tǒng)治人類(lèi) 時(shí)間: 2025-3-23 01:24 作者: DEVIL 時(shí)間: 2025-3-23 06:46
https://doi.org/10.1007/978-3-662-40180-4c factor against local tumour recurrence and also for cancer-specific survival [2–4]. This era of TME has evolved from the traditional “open” approach to minimal access surgeries, such as laparoscopy, robotics and more recently the transanal approach.作者: Narcissist 時(shí)間: 2025-3-23 11:28
https://doi.org/10.1007/978-3-662-13245-6for diagnosis, serum IgG4 levels, IgG4/IgG RNA ratio, and increased circulating plasmablast are helpful in diagnosing this disease. Steroid remains the main stay of therapy; however, some patients may require immunosuppressive treatment.作者: 推延 時(shí)間: 2025-3-23 14:41 作者: atopic-rhinitis 時(shí)間: 2025-3-23 22:05 作者: Diuretic 時(shí)間: 2025-3-23 22:58
IgG4 HPB Disease,for diagnosis, serum IgG4 levels, IgG4/IgG RNA ratio, and increased circulating plasmablast are helpful in diagnosing this disease. Steroid remains the main stay of therapy; however, some patients may require immunosuppressive treatment.作者: compel 時(shí)間: 2025-3-24 05:00
Book 2019cent surgical approaches in rectal cancer, tumor markers in HPB and GI malignancies, bridging therapy for hepatocellular carcinoma, adjuncts to liver resection, IgG-related HPB diseases, ERCP-induced perforations and superior mesenteric artery syndrome. As in the previous volumes, the chapter on adv作者: 使更活躍 時(shí)間: 2025-3-24 08:32
2367-3435 all-rounding chapter on advances in GI surgery.The 25th volume of this highly successful series covers a?range of interesting topics, including biological therapy in inflammatory bowel disease, recent surgical approaches in rectal cancer, tumor markers in HPB and GI malignancies, bridging therapy fo作者: FRAUD 時(shí)間: 2025-3-24 10:53
https://doi.org/10.1007/978-3-663-05130-5become an important part of the therapeutics of inflammatory bowel disease. The various biologics available, indications and efficacy of biologics in the management of inflammatory bowel diseases, the risks involved in their usage, and practical aspects in various clinical settings are discussed in the current review.作者: 大暴雨 時(shí)間: 2025-3-24 15:37
Methoden der Parameterbestimmung,noembryonic proteins, and oncoproteins) or carbohydrates. They may be elevated when there is no cancer (false positive) or may be normal or low when there is a cancer (false negative). They are usually measured in blood, urine, and other body fluids or identified in tumor tissue.作者: DEMN 時(shí)間: 2025-3-24 22:38 作者: 鑒賞家 時(shí)間: 2025-3-25 02:13
Ableitung der drei Integralgleichungen ,,en the two [1, 2]. The absence of peristalsis in the oesophageal body and failure of relaxation of the lower oesophageal sphincter (LES) manifest clinically as dysphagia, regurgitation and pain in the chest.作者: CHIP 時(shí)間: 2025-3-25 07:13 作者: Irremediable 時(shí)間: 2025-3-25 09:46 作者: aggravate 時(shí)間: 2025-3-25 11:48
T.K. Chattopadhyay (Editor-in-Chief),Peush Sahni,SProvides comprehensive reviews on topics of current interest in GI surgery.Written by experts working at best practices centers.Includes an all-rounding chapter on advances in GI surgery作者: Self-Help-Group 時(shí)間: 2025-3-25 19:19 作者: reflection 時(shí)間: 2025-3-25 20:17 作者: Ataxia 時(shí)間: 2025-3-26 01:43
GI Surgery Annual978-981-13-3227-2Series ISSN 2367-3435 Series E-ISSN 2367-3443 作者: 挖掘 時(shí)間: 2025-3-26 06:59
https://doi.org/10.1007/978-3-662-35077-5sophagus (commonest middle third), adenocarcinomas mostly occur in the distal one-third and the esophagogastric junction (EGJ). All adenocarcinomas involving the EGJ are included under the group of EGJ carcinomas; these include esophageal carcinomas, gastric carcinomas and true carcinomas of the car作者: Increment 時(shí)間: 2025-3-26 11:00
https://doi.org/10.1007/978-3-663-05130-5g of various immune mechanisms involved in the disease pathogenesis, various biologic drugs targeting the mediators in the inflammatory pathways have become an important part of the therapeutics of inflammatory bowel disease. The various biologics available, indications and efficacy of biologics in 作者: Diatribe 時(shí)間: 2025-3-26 13:04
https://doi.org/10.1007/978-3-662-40180-4n cause of cancer-related deaths. Professor Bill Heald was the first to describe the technique of total mesorectal excision (TME) in 1982. His landmark publication in 1986, revolutionized surgery for rectal cancer and TME, became the gold standard surgical technique for rectal cancer [1]. A complete作者: critique 時(shí)間: 2025-3-26 18:20
Methoden der Parameterbestimmung, produced in small quantities by normal cells. These substances are usually proteins (enzymes, hormones, DNA, RNA, mRNA, metabolites, receptors, carcinoembryonic proteins, and oncoproteins) or carbohydrates. They may be elevated when there is no cancer (false positive) or may be normal or low when t作者: Phonophobia 時(shí)間: 2025-3-26 21:49
https://doi.org/10.1007/978-3-662-13245-6 liver, pancreas, or biliary tree in various combinations and termed as IgG4 hepatopathy, autoimmune pancreatitis type-1 (AIP-1), or IgG4 cholangiopathy, respectively. It is characterized by multi-organ fibroinflammatory condition with tumefactive lesions, dense lymphoplasmacytic infiltration, IgG4-作者: 無(wú)政府主義者 時(shí)間: 2025-3-27 04:06
https://doi.org/10.1007/978-3-662-29612-7 endoscopic sphincterotomy (ES) has become a prevalent procedure all over the world. Even though ES is a safe procedure, it carries a small but significant number of serious complications which include pancreatitis, bleeding, cholangitis and perforation.作者: 斜谷 時(shí)間: 2025-3-27 07:48 作者: Barter 時(shí)間: 2025-3-27 09:48
https://doi.org/10.1007/978-3-662-24875-1ry tree and its associated parenchyma, made largely of organized cords of hepatocytes. Carl Langenbuch is credited with performing the first elective liver resection in 1888. The initial approaches focussed on directly splitting the parenchyma by mechanical means (finger ‘fracture’ or ‘Kelly-clysis’作者: Introvert 時(shí)間: 2025-3-27 16:41 作者: ACRID 時(shí)間: 2025-3-27 19:39
Berechnung der Atomverteilungskurven,Duodenal compression between the aorta and superior mesenteric artery (SMA) is a rare condition. It is traditionally referred to as the superior mesenteric artery syndrome (SMAS) or Wilkie’s syndrome.作者: 清唱?jiǎng)?nbsp; 時(shí)間: 2025-3-28 00:17 作者: SUGAR 時(shí)間: 2025-3-28 04:51
Esophagogastric Junction (EGJ) Carcinoma: An Updated Review,sophagus (commonest middle third), adenocarcinomas mostly occur in the distal one-third and the esophagogastric junction (EGJ). All adenocarcinomas involving the EGJ are included under the group of EGJ carcinomas; these include esophageal carcinomas, gastric carcinomas and true carcinomas of the car作者: 怒目而視 時(shí)間: 2025-3-28 07:24 作者: 滔滔不絕地講 時(shí)間: 2025-3-28 13:05 作者: Alveoli 時(shí)間: 2025-3-28 16:34
Tumor Markers in GI and HPB Cancers, produced in small quantities by normal cells. These substances are usually proteins (enzymes, hormones, DNA, RNA, mRNA, metabolites, receptors, carcinoembryonic proteins, and oncoproteins) or carbohydrates. They may be elevated when there is no cancer (false positive) or may be normal or low when t作者: MEAN 時(shí)間: 2025-3-28 21:52 作者: 思鄉(xiāng)病 時(shí)間: 2025-3-28 23:38 作者: Orchiectomy 時(shí)間: 2025-3-29 05:20 作者: 設(shè)想 時(shí)間: 2025-3-29 07:16
Adjuncts to Liver Resection,ry tree and its associated parenchyma, made largely of organized cords of hepatocytes. Carl Langenbuch is credited with performing the first elective liver resection in 1888. The initial approaches focussed on directly splitting the parenchyma by mechanical means (finger ‘fracture’ or ‘Kelly-clysis’
